SAN MATEO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) today announced Srinivasan Raghavan as its new Chief Product Officer (CPO) with over two decades of leadership experience in the enterprise SaaS industry. Srini will lead …
Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders Approve the Merger Following Review of Strategic Alternatives – …
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a technology company in Defense, National Security and Global Markets, is proud to announce its participation as a Gold Sponsor of the upcoming …
Tustin, Ca, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded its Canon Medical Systems USA, Inc./RSNA Research Scholar Grant to Jaehoon Shin, M.D., Ph.D. and the Canon …
DENVER, Dec. 02, 2024 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID”), a leading provider of biometric identity verification and authentication solutions, today announced Berify, an authentication, consumer experience & signal harnessing …
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and …
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 02 déc. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (Merus, la Société, nous ou notre), une société du secteur de l’oncologie au stade clinique développant les anticorps multispécifiques de pleine …
ARLINGTON, Va., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Tria Federal (Tria), the premier middle-market Technology and Advisory services provider delivering mission-critical digital transformation solutions to Federal Health and Public Safety agencies, today …
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, das Unternehmen, wir oder unser), ein im klinischen Stadium tätiges Onkologieunternehmen, das innovative, multispezifische Antikörper …
Miami, FL, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Interstellar Communication Holdings Inc. (the “Company” or “Interstellar Communication”), a holding company that connects and consolidates space-related companies, is pleased to announce a partnership with …
TAIPEI, Taiwan, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) ("APWC" or the "Company"), a leading manufacturer of wire and cable products for the telecommunications and electric- …
CALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Total Energy Services Inc. (“Total Energy”) (TSX:TOT) announces that its Board of Directors has declared a quarterly dividend of $0.09 (Cdn.) per common share for the quarter ending December 31, 2024 on …
HOUSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing on cannabis reclassification. Representing CBIH at this critical event in …
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse …
This news release constitutes a “designated news release” for the purposes of CAPREIT’s prospectus supplement dated February 22, 2024, to its short form base shelf prospectus dated May 9, 2023. TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Canadian Apartment …
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, …
AI-081 is a differentiated bispecific antibody with robust cooperative interactions between PD1 and VEGF Dosing of first patient in BIPAVE-001 Phase 1/2 trial expected in Q1 2025 ROCKVILLE, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage …
SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management …
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Critical Metals Corp (Nasdaq: CRML) (“Critical Metals Corp” or “the Company”), a leading mining development company focused on critical metals and minerals and producing strategic products essential to …
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative first in class immunotherapies for solid tumors, today announced that Charles …
